Synthetic peptide-coated bone mineral for enhanced osteoblastic activation in vitro and in vivo

Journal of Biomedical Materials Research - Part A

Volumn 87, Issue 3, 2008, Pages 688-697

  Lee, Jue Yeon ^a,b   Choo, Jung Eun ^a   Park, Hyun Jung ^b   Park, Jun Bum ^a   Lee, Sang Chul ^a,b   Lee, Seung Jin ^a,c   Park, Yoon Jeong ^a,b   Chung, Chong Pyoung ^a,b  

^a Seoul National University   (South Korea)

^b Nano Intelligent Biomedical Engineering Corporation (NIBEC)   (South Korea)

^c Ewha Womans University   (South Korea)

Author keywords

BMP receptor; Bone mineral; Bone morphogenetic protein 2; Bone regeneration; Synthetic peptide

Indexed keywords

AMINES; COATINGS; CONCENTRATION (PROCESS); DIFFERENTIATION (CALCULUS); ENZYME ACTIVITY; MINERALOGY; MINERALS; MINING; PEPTIDES; PROTEINS; SILICA; SILICATE MINERALS;

BMP RECEPTOR; BONE MINERAL; BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; SYNTHETIC PEPTIDE;

BONE;

ADENOSINE RECEPTOR; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; GLUTAMIC ACID; INORGANIC COMPOUND; MITOGEN ACTIVATED PROTEIN KINASE; PROCOLLAGEN C PROTEINASE; PROTEIN P2; SIGNAL PEPTIDE; SMAD PROTEIN; SYNTHETIC PEPTIDE; BONE MORPHOGENETIC PROTEIN RECEPTOR; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; BONE GRAFT; BONE MINERAL; BONE MINERALIZATION; BONE REGENERATION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; COW; ENZYME ACTIVITY; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; SERUM; SIGNAL TRANSDUCTION; WASTE; ANIMAL; BONE PROSTHESIS; CATTLE; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; MALE; METABOLISM; OSTEOBLAST; RABBIT;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS; BONE REGENERATION; BONE SUBSTITUTES; CATTLE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COATED MATERIALS, BIOCOMPATIBLE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; OSTEOBLASTS; OSTEOGENESIS; PEPTIDES; RABBITS; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 56349090949     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31721     Document Type: Article

References (31)

1. Lee JY, Nam SH, Im SY, Park YJ, Lee YM, Seol YJ, Chung CP, Lee SJ. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release 2002;78:187-197.
2. de Boer HH. The history of bone grafts. Clin Orthop Relat Res 1988;(226):292-298.
3. Schilephake H. Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 2002;31:469-484.
4. Schmitt JM, Hwang K, Winn SR, Hollinger JO. Bone morphogenetic proteins: An update on basic biology and clinical relevance. J Orthop Res. 1999;17:269-278.
5. Park YJ, Ku Y, Chung CP, Lee SJ. Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. J Control Release 1998;51:201-211.
6. Nimni ME. Polypeptide growth factors: Targeted delivery systems. Biomaterials 1997;18:1201-1225.
7. Thaller SR, Dart A, Tesluk H. The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague-Dawley rats. Ann Plast Surg 1993;31:429-433.
8. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM. Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843-9847.
9. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-252.
10. Koempel JA, Patt BS, O'Grady K, Wozney J, Toriumi DM. The effect of recombinant human bone morphogenetic pro tein-2 on the integration of porous hydroxyapatite implants with bone. J Biomed Mater Res 1998;41:359-363.
11. Mao T, Wang C, Zhang S, Wang H, Zhao M, Chen F, Ma Q, Han L. An experimental study on rhBMP-2 composite bone substitute for repairing craniomaxillary bone defects. Chin J Dent Res 1998;1:21-25.
12. Seol YJ, Park YJ, Lee SC, Kim KH, Lee JY, Kim TI, Lee YM, Ku Y, Rhyu IC, Han SB, Chung CP. Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-2. J Biomed Mater Res A 2006;77:599-607.
13. Kirsch T, Sebald W, Dreyer MK. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat Struct Biol 2000;7:492-496.
14. Nickel J, Dreyer MK, Kirsch T, Sebald W. The crystal structure of the BMP-2:BMPR-IA complex and the generation of BMP-2 antagonists. J Bone Joint Surg Am 2001;83A (Suppl 1, Pt 1):S7-S14.
15. Saito A, Suzuki Y, Ogata S, Ohtsuki C, Tanihara M. Activation of osteo-progenitor cells by a novel synthetic peptide derived from the bone morphogenetic protein-2 knuckle epitope. Biochim Biophys Acta 2003;1651:60-67.
16. Tye CE, Rattray KR, Warner KJ, Gordon JA, Sodek J, Hunter GK, Goldberg HA. Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. J Biol Chem 2003;278:7949-7955.
17. Friedman M. Absorption and Utilization of Amino Acids. Boca Raton, Fla.: CRC Press; 1989. p v.
18. Kalghatgi K, Ambrus CM, Horvath C, Karakousis CP, Sharma SD, Barren E. Determination of aromatic amino acids by ion-pair reversed-phase liquid chromatography in human sera from healthy and phenylketonuric individuals. Res Commun Chem Pathol Pharmacol 1984;45:253-259.
19. Fujisawa R, Wada Y, Nodasaka Y, Kuboki Y. Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals. Biochim Biophys Acta 1996;1292:53-60.
20. Kasugai S, Fujisawa R, Waki Y, Miyamoto K, Ohya K. Selective drug delivery system to bone: Small peptide (Asp)6 conjugation. J Bone Miner Res 2000;15:936-943.
21. Qian JJ, Bhatnagar RS. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res 1996;31:545-554.
22. Lou J, Tu Y, Li S, Manske PR. Involvement of ERK in BMP-2 induced osteoblastic differentiation of mesenchymal progenitor cell line C3H10T1/2. Biochem Biophys Res Commun 2000;268:757-762.
23. Xiao G, Gopalakrishnan R, Jiang D, Reith E, Benson MD, Franceschi RT. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells. J Bone Miner Res 2002;17:101-110.
24. Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic proteins-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 2001;28:491-498.
25. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC. Runx2 is a common target of transforming growth factor betal and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000;20:8783-8792.
26. Katagiri T, Yamaguchi A, Ikeda T, Yoshiki S, Wozney JM, Rosen V, Wang EA, Tanaka H, Omura S, Suda T. The non-osteogenic mouse pluripotent cell line. C3H10T1/2 is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophys Res Commun 1990;172:295-299.
27. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127(6 Pt 1):1755-1766.
28. Nishimura R, Hata K, Harris SE, Ikeda F, Yoneda T. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 2002;31:303-312.
29. Iba K, Takada J, Yamashita T. The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metab 2004;22:594-596.
30. Hay E, Hott M, Graulet AM, Lomri A, Marie PJ. Effects of bone morphogenetic protein-2 on human neonatal calvaria cell differentiation. J Cell Biochem 1999;72:81-93.
31. Itoh S, Kikuchi M, Takakuda K, Koyama Y, Matsumoto HN, Ichinose S, Tanaka J, Kawauchi T, Shinomiya K. The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2. J Biomed Mater Res 2001;54:445-453.